Filing Details

Accession Number:
0000905718-21-001541
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-26 13:30:47
Reporting Period:
2021-11-23
Accepted Time:
2021-11-26 13:30:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1853816 Dermata Therapeutics Inc. DRMA Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1279191 T Gerald Proehl C/O Dermata Therapeutics, Inc.
3525 Del Mar Heights Rd., #332
San Diego CA 92130
President, Ceo And Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-23 20,000 $2.40 59,512 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 17,857 Indirect By Allison Taylor Proehl 2020 Irrevocable Trust
Common Stock 8,928 Indirect By Meghan Proehl Wilder 2020 Irrevocable Trust
Common Stock 35,767 Indirect By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Common Stock 2,905,544 Indirect By Proehl Investment Ventures LLC
Common Stock 152,857 Indirect By Proehl Family Trust
Footnotes
  1. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.